November 16 - 20, 2013; Dallas, Texas
This coverage is not sanctioned by, nor a part of, the American Heart Association.
Medscape Cardiology© WebMD, LLC
What Can We Learn From a Negative Trial?
Dr. Clyde Yancy on Recent Heart Failure Studies
The RADAR-AF Trial: Take Another Look
Cholesterol Guidelines and CV Risk Calculator Clarifications
Lessons From the Resuscitation Sessions at AHA
Integrating Novel Oral Anticoagulants Into Clinical Practice
COAG: Does Genetic Testing Help With Warfarin Dosing?
Keeping Positive About Negative Trials at National Heart Meetings
The Future for NOACs in Light of ENGAGE-AF
Guest Christian Ruff: ENGAGE-AF and NOAC Meta-analysis
STREAM: Reassurance that TNK Is Second Best
Women Are as Old as Their Microvasculature: 10 Years Post-Go Red
Stories of Tony, Jess, and Ileana: Opening Session AHA 2013
Say It Isn't So . . . In the Treatment of Typical Atrial Flutter, Less May Not Be More
Chelation Therapy: Promising for Diabetic Patients but Disruptive to the Medical Establishment
Portable Ultrasound as the Stethoscope of the Future: Is It the Snapchat of Formal Echocardiography?
AHA 2013 Day 1: Improving Survival in Cardiac Arrest—A worthy goal!